![]() | Up a level |
Richards, Alexander, Leonenko, Ganna M, Walters, James Tynan Rhys, Kavanagh, D, Rees, Elliott, Evans, Anna, Chambert, K. D., Moran, J. L., Goldstein, J., Neale, B. M., McCarroll, S. A., Pocklington, Andrew, Holmans, Peter Alan, Owen, Michael John and O'Donovan, Michael Conlon
2016.
Exome arrays capture polygenic rare variant contributions to schizophrenia.
Human Molecular Genetics
25
(5)
, pp. 1001-1007.
10.1093/hmg/ddv620
![]() |
|
Ostronoff, F., Othus, M., Lazenby, Michelle, Estey, E., Appelbaum, F. R., Evans, Anna, Godwin, J., Gilkes, Amanda F., Kopecky, K. J., Burnett, Alan, List, A. F., Fang, M., Oehler, V. G., Petersdorf, S. H., Pogosova-Agadjanyan, E. L., Radich, J. P., Willman, C. L., Meshinchi, S. and Stirewalt, D. L. 2015. Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council report. Journal of Clinical Oncology 33 (10) , pp. 1157-1164. 10.1200/JCO.2014.58.0571 |
![]() |
Walter, R B, Othus, M, Burnett, A K, Löwenberg, B, Kantarjian, H M, Ossenkoppele, G J, Hills, Robert Kerrin, Ravandi, F, Pabst, T, Evans, Anna, Pierce, S R, Vekemans, M-C, Appelbaum, F R and Estey, E H 2014. Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center. Leukemia 29 (2) , pp. 312-320. 10.1038/leu.2014.242 |
![]() |
Lazenby, Michelle, Gilkes, Amanda, Marrin, C., Evans, Anna, Hills, Robert Kerrin and Burnett, A. K. 2014. The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial. Leukemia 28 , pp. 1953-1959. 10.1038/leu.2014.90 |
![]() |
Walter, R. B., Othus, M., Burnett, Alan K., Lowenberg, B., Kantarjian, H. M., Ossenkoppele, G. J., Hills, Robert Kerrin, van Montfort, K. G. M., Ravandi, F., Evans, Anna, Pierce, S. R., Appelbaum, F. R. and Estey, E. H. 2013. Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients. Blood 121 (13) , p. 2424. 10.1182/blood-2012-10-462440 |
![]() |